Introduction
Coronary heart disease (CHD) is a leading cause of death for both men and women in the United States. CHD is characterized by the formation of atherosclerosis, the narrowing of the arteries that supply oxygen and blood to the heart (Lloyd-Jones et al., 2009) . While CHD is a multifactorial disease, elevated total and low density lipoprotein (LDL) cholesterol and decreased high density lipoproeffective cholesterol-lowering therapy and are widely prescribed (Stein, 2003) , but they are costly and can cause severe side effects such as elevated serum levels of liver enzymes, skeletal muscle abnormalities, cognitive impairment, and even death (Evans and Rees, 2002; Farmer, 2003) .
Food-derived alternative cholesterol-lowering agents include dietary fiber, soy protein, and phytosterols . Phytosterols, as free sterols or esterified to fatty acids, can play an important role in the reduction of plasma cholesterol in humans (Katan et al., 2003) , especially for individuals who cannot tolerate statins or other cholesterol-lowering drugs. A recent study in our laboratory indicated that whole kernel grain sorghum lipid extract reduced cholesterol absorption and plasma non-HDL cholesterol concentration in hamsters (Carr et al., 2005) , which was attributed to phytosterols (and, possibly, policosanols) present in the whole kernel extract. Grain sorghum is a rich source of many phytochemicals (Awika and Rooney, 2004 ), yet this abundant cereal crop has been largely overlooked for its health benefits (Dicko et al., 2006) . Historical concerns raised most often regarding grain sorghum are its poor digestibility, low protein content and quality, deficiency of Vitamins A and E, and low bioavailability of zinc and iron (FAO, 1995) . More current research has emphasized that the antioxidant properties of polyphenolic compounds in many sorghum varieties may outweigh the disadvantages and that household processing techniques can overcome antinutritional properties (Awika and Rooney, 2004; Hotz and Gibson, 2007) .
The purpose of this research was to determine whether lipid extracts of sorghum distillers dried grain with solubles (DDGS) had cholesterol-lowering properties similar to extracts of sorghum whole kernels. DDGS is a byproduct of the ethanol industry and is primarily used for animal feed, yet many of the phytochemicals present in whole kernels are retained in the DDGS after starch depletion (Hwang et al., 2004) . Male Syrian hamsters were used to document the impact of DDGS lipid extract on plasma and liver cholesterol, sterol and bile acid excretion, and expression of genes involved in sterol metabolism.
Materials and methods

Animal care
Male F 1 B Syrian hamsters (Bio Breeders, Watertown, MA) aged 7 wk and weighing ~80 g were randomly assigned to treatment groups (n = 8-10/treatment) and housed individually in polycarbonate cages with sawdust bedding. Hamsters were kept in a 25 °C room with a 12-h light:dark cycle and had free access to food and water throughout the 4-wk feeding period. All experimental procedures were approved by the Institutional Animal Care and Use Committee at the University of Nebraska (protocol #04-12-059).
Diets
Hamsters were fed a modified AIN-93M diet supplemented with 0.0%, 0.5%, 1.0%, or 5.0% (w/w) lipids extracted from sorghum DDGS ( Table 1 ). The sorghum DDGS was obtained in 2006 from Energy Partners (now White Energy, Russell, Kansas) that processes mixed commercial grain sorghum hybrids for ethanol. A bench-scale extractor, as constructed by Weller et al. (2006) , was used to extract the lipids from the DDGS samples.Ta
Plasma and liver lipids
On day 28, hamsters were euthanized by CO 2 asphyxiation. Blood was collected by cardiac puncture using 10-mL syringes containing 10 mg ethylenediaminetetraacetic acid (EDTA) as an anticoagulant. Red blood cells were removed by centrifugation at 1000 g for 30 m at 4 °C. Aprotinin (1 mg/L) and phenylmethylsulphonyl fluoride (80 mg/L) were added to the plasma as preservatives. Plasma total cholesterol concentration was determined enzymatically using a microplate method (Carr et al., 1993) . Plasma HDL cholesterol concentration was measured after apolipoprotein B precipitation, and non-HDL cholesterol (VLDL + LDL) was calculated by difference. Previous hamster studies in our laboratory showed that the non-HDL plasma fraction contains >90% LDL cholesterol . Livers were perfused with saline through the portal vein to eliminate residual blood before being excised. Livers were weighed, immediately frozen in liquid nitrogen, and stored at -80 °C. Aliquots of frozen liver were minced and lipids extracted into chloroform/methanol (2:1, v/v) (Folch et al., 1957) . Total cholesterol, free cholesterol, triacylglycerol, and phospholipid were quantified enzymatically (Carr et al., 1993) , and liver esterified cholesterol was calculated as the difference between total and free cholesterol.
Fecal sterol analysis
Feces were collected during wk 4 for quantification of cholesterol-derived neutral steroids and bile acids. The following neutral steroids were quantified and represent fecal cholesterol and its metabolites: cholesterol, coprostanol, dihydrocholesterol, epicoprostanol, epicholestanol, copros- tanone, and cholestanone. Ground feces (~100 mg) were acidified by adding 0.2 mL of 0.5 mol/L HCl. Lipids were then extracted into chloroform/methanol (2:1, v/v) (Folch et al., 1957) containing 10 mg/L 5-cholestane as an internal standard. The lower phase solvent was evaporated and the samples saponified in 2 mL of 1 mol/L methanolic KOH for 1 h at 50 °C. After the addition of 2 mL deionized water, the fecal steroids were extracted into 5 mL hexane. The hexane was evaporated under nitrogen and the steroids derivatized and analyzed by gas chromatography as previously described . Fecal bile acid concentration was quantified enzymatically as previously described .
Total RNA isolation and quantitative real-time PCR
Liver samples (~0.5 g) were used for total RNA extraction using TRIzol reagent (Invitrogen, Carlsbad, CA) following the manufacturer's protocol. Reverse transcription for cDNA synthesis and quantitative real-time PCR analysis were performed as previously described Rasmussen et al., 2008) . Primers listed in Table 2 for the following genes were designed according to GenBank database using the Primer Express 3.0 software provided by ABI: Niemann-Pick C1 like 1 (NPC1L1), scavenger receptor class B type 1 (SRB1), sterol regulatory element binding protein-2 (SREBP2), 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR), LDL receptor (LDLR), ATP-binding cassette transporter A1 (ABCA1), cholesterol 7-hydroxylase (CYP7A1), and glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
Statistical analysis
All data are expressed as means ± SEM. Data were found to be normally distributed; therefore, treatment differences were determined by one-way ANOVA, followed by Student-Newman-Keuls multiple comparison procedure (GraphPad Prism 5, La Jolla, CA). Pearson correlation was used to compare fecal sterol excretion and liver cholesterol concentration. Mean differences were considered significant at P < 0.05.
Results
Hamster body weights were not significantly different among the treatment groups at any point during the 4 wk study. Hamsters continued to grow (average gain 22.7 ± 0.5 g/4 wk) and appeared healthy throughout the study. In subsequent calculations in which metabolic data are normalized to 100 g of body weight, we used individual body weights as measured on the final day of the study.
Plasma non-HDL cholesterol concentration was significantly lower in hamsters fed 5.0% DDGS lipids compared to 0.5% DDGS lipids and tended to be lower compared to the other groups (Table 3) . Plasma HDL cholesterol was also significantly lower in the 5.0% DDGS lipids group compared to the others, which was expected since hamsters are considered an "HDL mammal" (Trautwein et al., 1993) . Plasma triacylglycerol concentration was not significantly affected by the level of DDGS lipids consumed.
Liver weights, normalized to 100 g body wt, were not significantly different among treatments (Table 4) . Liver free cholesterol and esterified cholesterol concentrations were significantly lower in the 5.0% DDGS lipids group compared to hamsters fed 0.5% DDGS lipids, whereas liver triacylglycerol was significantly higher in the 1.0% and 5.0% DDGS groups (Table 4) . Liver phospholipid concentration was not significantly affected by the level of DDGS lipids consumed.
Hepatic gene expression of NPC1L1, SRB1, SREBP2, HMGR, LDLR, and CYP7A1 was not significantly different Table 2 . Real-time PCR primers.
Gene
Forward primer Reverse primer
Values are means ± SEM, n = 8-10. Means in the same column having different superscripts are significantly different (P < 0.05). Values are means ± SEM, n = 8-10. Means in the same column having different superscripts are significantly different (P < 0.05).
among treatment groups (Table 5 ). However, liver ABCA1 expression was significantly higher in hamsters fed 5.0% DDGS lipids compared to controls and 0.5% DDGS group. ABCA1 expression in hamsters fed 0.5% and 1.0% DDGS lipids were not significantly different compared to controls. Cholesterol excretion from the body was represented by both fecal bile acid and fecal neutral steroid output, expressed as μmol per day, normalized to 100 g body wt (Table 6). Fecal total bile acids were not significantly different among groups; however, fecal neutral steroid output increased in parallel with increased intake of DDGS lipids. Fecal neutral steroids accounted for the majority (>91%) of total sterol output.
A strong negative correlation (r = -0.97, P = 0.026) was observed between fecal cholesterol excretion and liver cholesterol concentration (Figure 1) , suggesting a dependency of liver cholesterol concentration on intestinal cholesterol uptake. Consequently, liver cholesterol concentration was strongly correlated with plasma total cholesterol (r = 0.96, P = 0.041).
Discussion
This hamster study was conducted to determine the influence of sorghum DDGS lipid extract on several aspects of cholesterol metabolism known to influence human health. Previous experiments showed that grain sorghum lipid extracted from whole kernels significantly lower plasma and liver cholesterol. Grain sorghum lipid extract appeared to exert its cholesterol-lowering effect by reducing cholesterol absorption with a concomitant increase in fecal sterol excretion as its primary mechanism of action (Carr et al., 2005) . Our current findings indicate similar metabolic responses when hamsters were fed the lipid fraction extracted from sorghum DDGS.
Our assumption was that lipids extracted from either whole kernels or DDGS would consist of similar components, and that increased cholesterol excretion (i.e., decreased cholesterol absorption) was most likely caused by plant sterols. Several studies in humans and animals have demonstrated the ability of dietary plant sterols to inhibit cholesterol absorption and reduce plasma LDL cholesterol concentration (Law, 2000; Katan et al., 2003; Ostlund, 2004) . Plant sterol ester fortified foods for human consumption have been shown to lower LDL cholesterol levels up to 15% compared to placebo when administrated doses of 1-3 g/day (Katan et al., 2003) . Accordingly, the National Cholesterol Education Program (2002) and the American Heart Association (Lichtenstein et al., 2006) now recommend a diet that contains 2 g/d of plant sterol esters as an effective cholesterol-lowering therapy. We have shown that plant sterols reduce the amount of intestinal cholesterol uptake into enterocytes by their ability to disrupt the incorporation of cholesterol into micelles, thereby lowering cholesterol absorption .
Cholesterol-lowering effects occurred with hamsters fed 5.0% DDGS lipids compared to lower amounts of DDGS lipid intake. With regard to plasma lipid response, hamster non-HDL (or LDL) cholesterol responds similarly to humans when presented with a dietary challenge, making them a useful animal model (Trautwein et al., 1993) . Therefore, significant decrease in non-HDL cholesterol in hamsters suggests that sorghum DDGS lipid extracts could provide health benefits to human when incorporated into a normal diet. Values are means ± SEM, n = 8-10. Means in the same column having different superscripts are significantly different (P < 0.05). Values are means ± SEM (n = 8-10) of relative units normalized to the housekeeping gene, GAPDH. Means in the same column having different superscripts are significantly different (P < 0.05). Values are means ± SEM, n = 8-10. Means in the same column having different superscripts are significantly different (P < 0.05).
A significant reduction in both free and esterified cholesterol in the liver was seen in the 5.0% DDGS lipid group. Hamsters fed 5.0% DDGS lipids exhibited a significant reduction compared to other groups in esterified cholesterol concentration, with a 54% reduction compared to control. While the reduction of free cholesterol was significant, the magnitude of change among treatment groups was relatively small indicating that free cholesterol in cell membranes is tightly regulated due to its essential role in cell metabolism. The trend of increasing liver triacylglycerol possibly indicates that secretion of VLDL is decreased (Wang et al., 2005) , although this was not measured in the current study. Liver phospholipid is an indicator of cell mass and was not affect by dietary treatment.
Fecal neutral sterol excretion was significantly higher in all DDGS lipid groups compared to control, with the 5.0% DDGS group exhibiting a 66% increase compared to controls. Fecal bile acids also represent an excretory pathway for cholesterol, although intake of DDGS lipids did not affect bile acid output or gene expression of CYP7A1. These observations therefore indicate that DDGS lipid extract exerts its cholesterol-lowering effect primarily by promoting excretion of intestinal neutral sterols (i.e., cholesterol and its metabolites).
Policosanols were previously reported in humans to lower LDL cholesterol (Varady et al., 2003) , possibly by inhibiting cholesterol synthesis (Menendez et al., 1994 (Menendez et al., , 1997 . With the assumption that the policosanol content of lipid extract from sorghum DDGS was similar to lipid extract from whole kernels (Carr et al., 2005) , and based on total food intake, hamsters in the present study consumed policosanols in the range of 23-230 mg d -1 kg -1 body wt. Clinical studies suggest that as little as 0.07 mg d -1 kg -1 can significantly reduce LDL cholesterol concentration (Varady et al., 2003) . In the present study, in which 3000-times more policosanol was presumably consumed compared to humans on a body weight basis, no changes were observed in gene expression of HMGR, indicating that policosanol intake in hamsters probably had little impact on regulating plasma cholesterol levels.
Grain sorghum contains phenolic compounds that are beneficial to cardiovascular health due to their ability to reduce inflammation, reduce LDL oxidation, improve endothelial function, and inhibit platelet aggregation (Awika and Rooney, 2004; Arts and Hollman, 2005; Vita, 2005) . Additionally, phenolic compounds have demonstrated a modest cholesterol-lowering ability in some studies (Lin et al., 1986; Santos-Buelga and Scalbert, 2000) . We did not directly test the effects of sorghum phenolic compounds, although their contribution to cholesterol-lowering should not be underestimated.
Conclusions
The current evidence suggests that sorghum DDGS lipid extract lowers plasma and liver cholesterol concentrations similarly to grain sorghum lipid extract from whole kernels. Mechanisms by which this occurs are due, at least in part, to increased fecal neutral sterol excretion (i.e., decreased cholesterol absorption). Grain sorghum is a rich source of phytochemicals, including plant sterols; therefore, lipid extracts from whole kernels or DDGS could provide health benefits when incorporated into human diets.
